Skip to content

Science1 publisher3 min readPublished

IL-1beta in provoked blood cells failed to flag gastric ulcers in 77 horses

Adelaide University researchers provoked immune cells from 77 horses and measured interleukin-1 beta. The response tracked neither gastric lesions nor facial pain scores in a cohort where 59 of the 64 analysed horses had lesions.

The Scientist · Science desk

Illustration accompanying IL-1beta in provoked blood cells failed to flag gastric ulcers in 77 horses

What happened

  • Veterinarians still cannot reliably tell which horses with gastric ulcers are in pain, or how clinically significant a given lesion is.
  • Adelaide University veterinarians drew blood from 77 horses, provoked the immune cells in it, and measured how much interleukin-1 beta those cells produced, publishing the work in The Veterinary Journal.
  • Only a quarter of the horses produced a measurable response to the stimulation, and that response was not significantly associated with the presence of equine gastric ulcer syndrome.

Compiled by The ScientistSomething wrong?How this is made

Why it matters

  • constraint With five ulcer-free horses in the analysed group, the null excludes only a large systemic signal, so interleukin-1 beta is untested at the effect sizes a clinician would act on.
  • decision A vet looking at an ulcer on an endoscopy image still decides whether to treat on clinical judgement, with no laboratory number to confirm or overrule the call.
  • precedent If the signal really is confined to the stomach wall, the next attempt needs sampling closer to the lesion, and that is a more invasive and more expensive study than a blood draw.

The paper's title calls the method an ex vivo toll-like receptor agonist response, and that is a capacity test [3]. Blood is drawn, the cells in it are provoked with agonists, and the readout is how much interleukin-1 beta those cells make in a tube [2]. Interleukin-1 beta was the target because it has been linked to pain and inflammation in other species [4]. Whether that link carries over to the horse was part of what was on trial.

Thirteen of the 77 sampled horses do not appear in the final analysis [18]. Of the 64 that do, 59 had gastric lesions, so the comparison group without lesions was five animals [6][19]. Five on one side can exclude a large difference between groups and not much else. The narrow reading of this null is that there is no systemic interleukin-1 beta signal big enough to show up against a five-animal reference [5].

The ulcer-free group was small for a reason: controls are the scarce sample in this population. Gastric ulcers affect a large proportion of horses, and previous studies have reported gastric disease in 80% to 100% of racehorses for one major form of the disease [17][9].

The quarter of horses that responded at all is a separate problem from the group comparison. Counted from the 64 analysed, that is about 16 responders and 48 non-responders [20]. An assay that reads flat in three horses out of four will not grade pain in an individual animal even if the group difference had reached significance.

One comparison in the study does not lean on the five controls. The researchers split the horses by whether they responded to the stimulation and compared facial pain scores between those two groups, and found no significant difference [8]. That test had roughly 16 animals against 48 [20].

Gustavo Ferlini Agne, of Adelaide University's School of Animal and Veterinary Sciences [21], described the clinical problem in terms of the patient. "Horses can't tell us when they are in pain, and signs of discomfort can be subtle, inconsistent or easily overlooked," Agne said [13]. He also said the negative result has value of its own. "This is an important step because knowing what doesn't work is just as valuable as identifying a promising test," he said [15].

The researchers are explicit that none of this shows gastric ulcers are painless [10]. Their explanation for the null is anatomical: the immune response measured in circulating blood cells may not be sensitive enough to detect the effects of the ulcers, particularly if the inflammation or pain is localized to the stomach [11]. Agne said larger studies and horse-specific testing methods will be needed [12]. "The next challenge is to develop approaches that are better suited to horses and combine biological measures with careful assessment of pain-related behavior and inflammation," he said [23].

What to watch

  • Whether the full Veterinary Journal paper reports effect sizes and confidence intervals for the responder comparison, not only significance.
  • A follow-up that samples gastric mucosa instead of circulating blood, which would test the localisation explanation directly.
  • Whether anyone can recruit enough ulcer-free horses to power the case-control comparison this cohort could not.
Loading claim ledger
Loading source directory links
Loading share composer
Loading topic controls
Loading related stories